Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bethanechol versus domperidone for pediatric feeding intolerance
IRCT20251121068063N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in feeding intolerance comparing Bethanechol with Domperidone control (2 arms). Primary endpoints: Absence of gastric residue, Absence of abdominal distension and 2 more. Started Nov 2025; status: completed.
02
Drugs
bethanecholdomperidone
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on IRCT20251121068063N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251121068063N1.